Targeted Gene Silencing BRAF Synergized Photothermal Effect Inhibits Hepatoma Cell Growth Using New GAL-GNR-siBRAF Nanosystem
Abstract Liver cancer is one of the most common malignancies worldwide. The RAF kinase inhibitors are effective in the treatment of hepatocellular carcinoma (HCC); therefore, inhibition of the BRAF/MEK/ERK pathway has become a new therapeutic strategy for novel HCC therapy. However, targeted specifi...
Main Authors: | Yanling Liu, Manman Tan, Yujuan Zhang, Wei Huang, Liangliang Min, Shanshan Peng, Keng Yuan, Li Qiu, Weiping Min |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2020-05-01
|
Series: | Nanoscale Research Letters |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s11671-020-03340-x |
Similar Items
-
Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one case of BRAF-mutated Rosai-Dorfman disease
by: Christopher Cronin, et al.
Published: (2022-12-01) -
Arthralgia Induced by BRAF Inhibitor Therapy in Melanoma Patients
by: Martin Salzmann, et al.
Published: (2020-10-01) -
BRAF Modulates Lipid Use and Accumulation
by: Jacqueline A. Turner, et al.
Published: (2022-04-01) -
<i>BRAF</i> Inhibitors in <i>BRAF-Mutated</i> Colorectal Cancer: A Systematic Review
by: Wajeeha Aiman, et al.
Published: (2023-12-01) -
SPOP inhibits BRAF-dependent tumorigenesis through promoting non-degradative ubiquitination of BRAF
by: Kai Feng, et al.
Published: (2022-12-01)